The role of individual domains and the significance of shedding of ATP6AP2/(pro)renin receptor in vacuolar H(+)-ATPase biogenesis

PLoS One. 2013 Nov 4;8(11):e78603. doi: 10.1371/journal.pone.0078603. eCollection 2013.

Abstract

The ATPase 6 accessory protein 2 (ATP6AP2)/(pro)renin receptor (PRR) is essential for the biogenesis of active vacuolar H(+)-ATPase (V-ATPase). Genetic deletion of ATP6AP2/PRR causes V-ATPase dysfunction and compromises vesicular acidification. Here, we characterized the domains of ATP6AP2/PRR involved in active V-ATPase biogenesis. Three forms of ATP6AP2/PRR were found intracellularly: full-length protein and the N- and C-terminal fragments of furin cleavage products, with the N-terminal fragment secreted extracellularly. Genetic deletion of ATP6AP2/PRR did not affect the protein stability of V-ATPase subunits. The extracellular domain (ECD) and transmembrane domain (TM) of ATP6AP2/PRR were indispensable for the biogenesis of active V-ATPase. A deletion mutant of ATP6AP2/PRR, which lacks exon 4-encoded amino acids inside the ECD (Δ4M) and causes X-linked mental retardation Hedera type (MRXSH) and X-linked parkinsonism with spasticity (XPDS) in humans, was defective as a V-ATPase-associated protein. Prorenin had no effect on the biogenesis of active V-ATPase. The cleavage of ATP6AP2/PRR by furin seemed also dispensable for the biogenesis of active V-ATPase. We conclude that the N-terminal ECD of ATP6AP2/PRR, which is also involved in binding to prorenin or renin, is required for the biogenesis of active V-ATPase. The V-ATPase assembly occurs prior to its delivery to the trans-Golgi network and hence shedding of ATP6AP2/PRR would not affect the biogenesis of active V-ATPase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoviridae / genetics
  • Adenoviridae / metabolism
  • Animals
  • Autophagy / genetics
  • Embryo, Mammalian
  • Fibroblasts / cytology
  • Fibroblasts / metabolism*
  • Furin / metabolism
  • Gene Expression
  • Genetic Vectors
  • Humans
  • Mice
  • Mutation
  • Primary Cell Culture
  • Protein Isoforms / chemistry
  • Protein Isoforms / genetics
  • Protein Isoforms / metabolism
  • Protein Structure, Tertiary
  • Proton-Translocating ATPases / antagonists & inhibitors
  • Proton-Translocating ATPases / chemistry*
  • Proton-Translocating ATPases / genetics
  • Proton-Translocating ATPases / metabolism
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / metabolism
  • Receptors, Cell Surface / antagonists & inhibitors
  • Receptors, Cell Surface / chemistry*
  • Receptors, Cell Surface / genetics
  • Receptors, Cell Surface / metabolism
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • Transfection
  • Vacuolar Proton-Translocating ATPases / antagonists & inhibitors
  • Vacuolar Proton-Translocating ATPases / chemistry*
  • Vacuolar Proton-Translocating ATPases / genetics
  • Vacuolar Proton-Translocating ATPases / metabolism
  • trans-Golgi Network / metabolism*

Substances

  • ATP6AP2 protein, human
  • ATP6AP2 protein, mouse
  • Protein Isoforms
  • RNA, Small Interfering
  • Receptors, Cell Surface
  • Recombinant Proteins
  • Furin
  • Vacuolar Proton-Translocating ATPases
  • Proton-Translocating ATPases

Grants and funding

This work was supported by a JSPS KAKENHI Grant Number 25293198 (to A.I.), a Grant-in-Aid for JSPS fellows (to K.K.), notable awards for research achievements in science and technology (Takeda Science Foundation), and the Mochida Memorial Foundation for Medical and Pharmaceutical Research (to M.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.